Omnicom Group Inc. Stock Outperforms Market On Strong Trading Day

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Omnicom Group Inc. Stock Outperforms Market On Strong Trading Day

5:25 pm ET December 1, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Omnicom Group Inc. (OMC) inched 0.13% higher to $79.86 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.09% to 4,076.57 and Dow Jones Industrial Average falling 0.56% to 34,395.01. This was the stock's third consecutive day of gains. Omnicom Group Inc. closed $11.75 below its 52-week high ($91.61), which the company reached on February 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Trade Desk Inc. Cl A (TTD) fell 0.44% to $51.91 and Gartner Inc. (IT) rose 1.68% to $356.27. Trading volume (1.6 M) eclipsed its 50-day average volume of 1.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2022.

(END) Dow Jones Newswires

December 01, 2022 17:25 ET (22:25 GMT)